The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Orlistat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Orlistat is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orlistat is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Orlistat include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Orlistat, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orlistat.
Report Scope
The Orlistat market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orlistat market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orlistat manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
ZEIN pharmaceutical
HISUN
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm
Segment by Type
120mg Orlistat
60mg Orlistat
Segment by Application
Weight-reducing Aid
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orlistat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Orlistat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Orlistat is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orlistat is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Orlistat include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Orlistat, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orlistat.
Report Scope
The Orlistat market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orlistat market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orlistat manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
ZEIN pharmaceutical
HISUN
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm
Segment by Type
120mg Orlistat
60mg Orlistat
Segment by Application
Weight-reducing Aid
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orlistat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orlistat Market Overview
1.1 Product Overview and Scope of Orlistat
1.2 Orlistat Segment by Type
1.2.1 Global Orlistat Market Value Comparison by Type (2024-2030)
1.2.2 120mg Orlistat
1.2.3 60mg Orlistat
1.3 Orlistat Segment by Application
1.3.1 Global Orlistat Market Value by Application: (2024-2030)
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Global Orlistat Market Size Estimates and Forecasts
1.4.1 Global Orlistat Revenue 2019-2030
1.4.2 Global Orlistat Sales 2019-2030
1.4.3 Global Orlistat Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orlistat Market Competition by Manufacturers
2.1 Global Orlistat Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orlistat Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orlistat Average Price by Manufacturers (2019-2024)
2.4 Global Orlistat Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orlistat, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orlistat, Product Type & Application
2.7 Orlistat Market Competitive Situation and Trends
2.7.1 Orlistat Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orlistat Players Market Share by Revenue
2.7.3 Global Orlistat Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orlistat Retrospective Market Scenario by Region
3.1 Global Orlistat Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orlistat Global Orlistat Sales by Region: 2019-2030
3.2.1 Global Orlistat Sales by Region: 2019-2024
3.2.2 Global Orlistat Sales by Region: 2025-2030
3.3 Global Orlistat Global Orlistat Revenue by Region: 2019-2030
3.3.1 Global Orlistat Revenue by Region: 2019-2024
3.3.2 Global Orlistat Revenue by Region: 2025-2030
3.4 North America Orlistat Market Facts & Figures by Country
3.4.1 North America Orlistat Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orlistat Sales by Country (2019-2030)
3.4.3 North America Orlistat Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orlistat Market Facts & Figures by Country
3.5.1 Europe Orlistat Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orlistat Sales by Country (2019-2030)
3.5.3 Europe Orlistat Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orlistat Market Facts & Figures by Country
3.6.1 Asia Pacific Orlistat Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orlistat Sales by Country (2019-2030)
3.6.3 Asia Pacific Orlistat Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orlistat Market Facts & Figures by Country
3.7.1 Latin America Orlistat Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orlistat Sales by Country (2019-2030)
3.7.3 Latin America Orlistat Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orlistat Market Facts & Figures by Country
3.8.1 Middle East and Africa Orlistat Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orlistat Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orlistat Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orlistat Sales by Type (2019-2030)
4.1.1 Global Orlistat Sales by Type (2019-2024)
4.1.2 Global Orlistat Sales by Type (2025-2030)
4.1.3 Global Orlistat Sales Market Share by Type (2019-2030)
4.2 Global Orlistat Revenue by Type (2019-2030)
4.2.1 Global Orlistat Revenue by Type (2019-2024)
4.2.2 Global Orlistat Revenue by Type (2025-2030)
4.2.3 Global Orlistat Revenue Market Share by Type (2019-2030)
4.3 Global Orlistat Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orlistat Sales by Application (2019-2030)
5.1.1 Global Orlistat Sales by Application (2019-2024)
5.1.2 Global Orlistat Sales by Application (2025-2030)
5.1.3 Global Orlistat Sales Market Share by Application (2019-2030)
5.2 Global Orlistat Revenue by Application (2019-2030)
5.2.1 Global Orlistat Revenue by Application (2019-2024)
5.2.2 Global Orlistat Revenue by Application (2025-2030)
5.2.3 Global Orlistat Revenue Market Share by Application (2019-2030)
5.3 Global Orlistat Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Orlistat Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 GSK group
6.2.1 GSK group Corporation Information
6.2.2 GSK group Description and Business Overview
6.2.3 GSK group Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK group Orlistat Product Portfolio
6.2.5 GSK group Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Orlistat Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz(Novartis)
6.4.1 Sandoz(Novartis) Corporation Information
6.4.2 Sandoz(Novartis) Description and Business Overview
6.4.3 Sandoz(Novartis) Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz(Novartis) Orlistat Product Portfolio
6.4.5 Sandoz(Novartis) Recent Developments/Updates
6.5 STADA-VN J.V.Co., Ltd
6.5.1 STADA-VN J.V.Co., Ltd Corporation Information
6.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
6.5.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.5.4 STADA-VN J.V.Co., Ltd Orlistat Product Portfolio
6.5.5 STADA-VN J.V.Co., Ltd Recent Developments/Updates
6.6 Hexal AG
6.6.1 Hexal AG Corporation Information
6.6.2 Hexal AG Description and Business Overview
6.6.3 Hexal AG Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hexal AG Orlistat Product Portfolio
6.6.5 Hexal AG Recent Developments/Updates
6.7 National Company for Pharmaceutical Industry
6.6.1 National Company for Pharmaceutical Industry Corporation Information
6.6.2 National Company for Pharmaceutical Industry Description and Business Overview
6.6.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.4.4 National Company for Pharmaceutical Industry Orlistat Product Portfolio
6.7.5 National Company for Pharmaceutical Industry Recent Developments/Updates
6.8 Lunan Pharmaceutical Group Corporation
6.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
6.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.8.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio
6.8.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.9 ZEIN pharmaceutical
6.9.1 ZEIN pharmaceutical Corporation Information
6.9.2 ZEIN pharmaceutical Description and Business Overview
6.9.3 ZEIN pharmaceutical Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZEIN pharmaceutical Orlistat Product Portfolio
6.9.5 ZEIN pharmaceutical Recent Developments/Updates
6.10 HISUN
6.10.1 HISUN Corporation Information
6.10.2 HISUN Description and Business Overview
6.10.3 HISUN Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HISUN Orlistat Product Portfolio
6.10.5 HISUN Recent Developments/Updates
6.11 Taj Pharmaceuticals Ltd
6.11.1 Taj Pharmaceuticals Ltd Corporation Information
6.11.2 Taj Pharmaceuticals Ltd Orlistat Description and Business Overview
6.11.3 Taj Pharmaceuticals Ltd Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Taj Pharmaceuticals Ltd Orlistat Product Portfolio
6.11.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
6.12 Kabir Life Sciences & Research
6.12.1 Kabir Life Sciences & Research Corporation Information
6.12.2 Kabir Life Sciences & Research Orlistat Description and Business Overview
6.12.3 Kabir Life Sciences & Research Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kabir Life Sciences & Research Orlistat Product Portfolio
6.12.5 Kabir Life Sciences & Research Recent Developments/Updates
6.13 DM Pharma
6.13.1 DM Pharma Corporation Information
6.13.2 DM Pharma Orlistat Description and Business Overview
6.13.3 DM Pharma Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.13.4 DM Pharma Orlistat Product Portfolio
6.13.5 DM Pharma Recent Developments/Updates
6.14 China Zhongshan Pharm
6.14.1 China Zhongshan Pharm Corporation Information
6.14.2 China Zhongshan Pharm Orlistat Description and Business Overview
6.14.3 China Zhongshan Pharm Orlistat Sales, Revenue and Gross Margin (2019-2024)
6.14.4 China Zhongshan Pharm Orlistat Product Portfolio
6.14.5 China Zhongshan Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orlistat Industry Chain Analysis
7.2 Orlistat Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orlistat Production Mode & Process
7.4 Orlistat Sales and Marketing
7.4.1 Orlistat Sales Channels
7.4.2 Orlistat Distributors
7.5 Orlistat Customers
8 Orlistat Market Dynamics
8.1 Orlistat Industry Trends
8.2 Orlistat Market Drivers
8.3 Orlistat Market Challenges
8.4 Orlistat Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Orlistat Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Orlistat Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Orlistat Market Competitive Situation by Manufacturers in 2023
Table 4. Global Orlistat Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Orlistat Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Orlistat Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Orlistat Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Orlistat Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Orlistat, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orlistat, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orlistat, Product Type & Application
Table 12. Global Key Manufacturers of Orlistat, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orlistat by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orlistat as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orlistat Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Orlistat Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Orlistat Sales Market Share by Region (2019-2024)
Table 19. Global Orlistat Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Orlistat Sales Market Share by Region (2025-2030)
Table 21. Global Orlistat Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Orlistat Revenue Market Share by Region (2019-2024)
Table 23. Global Orlistat Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Orlistat Revenue Market Share by Region (2025-2030)
Table 25. North America Orlistat Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Orlistat Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Orlistat Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Orlistat Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Orlistat Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Orlistat Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Orlistat Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Orlistat Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Orlistat Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Orlistat Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Orlistat Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Orlistat Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Orlistat Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Orlistat Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Orlistat Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Orlistat Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Orlistat Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Orlistat Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Orlistat Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Orlistat Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Orlistat Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Orlistat Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Orlistat Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Orlistat Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Orlistat Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Orlistat Sales (K Pcs) by Type (2019-2024)
Table 51. Global Orlistat Sales (K Pcs) by Type (2025-2030)
Table 52. Global Orlistat Sales Market Share by Type (2019-2024)
Table 53. Global Orlistat Sales Market Share by Type (2025-2030)
Table 54. Global Orlistat Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Orlistat Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Orlistat Revenue Market Share by Type (2019-2024)
Table 57. Global Orlistat Revenue Market Share by Type (2025-2030)
Table 58. Global Orlistat Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Orlistat Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Orlistat Sales (K Pcs) by Application (2019-2024)
Table 61. Global Orlistat Sales (K Pcs) by Application (2025-2030)
Table 62. Global Orlistat Sales Market Share by Application (2019-2024)
Table 63. Global Orlistat Sales Market Share by Application (2025-2030)
Table 64. Global Orlistat Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Orlistat Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Orlistat Revenue Market Share by Application (2019-2024)
Table 67. Global Orlistat Revenue Market Share by Application (2025-2030)
Table 68. Global Orlistat Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Orlistat Price (USD/Pcs) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Roche Orlistat Product
Table 74. Roche Recent Developments/Updates
Table 75. GSK group Corporation Information
Table 76. GSK group Description and Business Overview
Table 77. GSK group Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. GSK group Orlistat Product
Table 79. GSK group Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Teva Orlistat Product
Table 84. Teva Recent Developments/Updates
Table 85. Sandoz(Novartis) Corporation Information
Table 86. Sandoz(Novartis) Description and Business Overview
Table 87. Sandoz(Novartis) Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Sandoz(Novartis) Orlistat Product
Table 89. Sandoz(Novartis) Recent Developments/Updates
Table 90. STADA-VN J.V.Co., Ltd Corporation Information
Table 91. STADA-VN J.V.Co., Ltd Description and Business Overview
Table 92. STADA-VN J.V.Co., Ltd Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. STADA-VN J.V.Co., Ltd Orlistat Product
Table 94. STADA-VN J.V.Co., Ltd Recent Developments/Updates
Table 95. Hexal AG Corporation Information
Table 96. Hexal AG Description and Business Overview
Table 97. Hexal AG Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Hexal AG Orlistat Product
Table 99. Hexal AG Recent Developments/Updates
Table 100. National Company for Pharmaceutical Industry Corporation Information
Table 101. National Company for Pharmaceutical Industry Description and Business Overview
Table 102. National Company for Pharmaceutical Industry Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. National Company for Pharmaceutical Industry Orlistat Product
Table 104. National Company for Pharmaceutical Industry Recent Developments/Updates
Table 105. Lunan Pharmaceutical Group Corporation Corporation Information
Table 106. Lunan Pharmaceutical Group Corporation Description and Business Overview
Table 107. Lunan Pharmaceutical Group Corporation Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Lunan Pharmaceutical Group Corporation Orlistat Product
Table 109. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
Table 110. ZEIN pharmaceutical Corporation Information
Table 111. ZEIN pharmaceutical Description and Business Overview
Table 112. ZEIN pharmaceutical Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. ZEIN pharmaceutical Orlistat Product
Table 114. ZEIN pharmaceutical Recent Developments/Updates
Table 115. HISUN Corporation Information
Table 116. HISUN Description and Business Overview
Table 117. HISUN Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. HISUN Orlistat Product
Table 119. HISUN Recent Developments/Updates
Table 120. Taj Pharmaceuticals Ltd Corporation Information
Table 121. Taj Pharmaceuticals Ltd Description and Business Overview
Table 122. Taj Pharmaceuticals Ltd Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Taj Pharmaceuticals Ltd Orlistat Product
Table 124. Taj Pharmaceuticals Ltd Recent Developments/Updates
Table 125. Kabir Life Sciences & Research Corporation Information
Table 126. Kabir Life Sciences & Research Description and Business Overview
Table 127. Kabir Life Sciences & Research Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Kabir Life Sciences & Research Orlistat Product
Table 129. Kabir Life Sciences & Research Recent Developments/Updates
Table 130. DM Pharma Corporation Information
Table 131. DM Pharma Description and Business Overview
Table 132. DM Pharma Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. DM Pharma Orlistat Product
Table 134. DM Pharma Recent Developments/Updates
Table 135. China Zhongshan Pharm Corporation Information
Table 136. China Zhongshan Pharm Description and Business Overview
Table 137. China Zhongshan Pharm Orlistat Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 138. China Zhongshan Pharm Orlistat Product
Table 139. China Zhongshan Pharm Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Orlistat Distributors List
Table 143. Orlistat Customers List
Table 144. Orlistat Market Trends
Table 145. Orlistat Market Drivers
Table 146. Orlistat Market Challenges
Table 147. Orlistat Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Orlistat
Figure 2. Global Orlistat Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Orlistat Market Share by Type in 2023 & 2030
Figure 4. 120mg Orlistat Product Picture
Figure 5. 60mg Orlistat Product Picture
Figure 6. Global Orlistat Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Orlistat Market Share by Application in 2023 & 2030
Figure 8. Weight-reducing Aid
Figure 9. Other
Figure 10. Global Orlistat Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Orlistat Market Size (2019-2030) & (US$ Million)
Figure 12. Global Orlistat Sales (2019-2030) & (K Pcs)
Figure 13. Global Orlistat Average Price (USD/Pcs) & (2019-2030)
Figure 14. Orlistat Report Years Considered
Figure 15. Orlistat Sales Share by Manufacturers in 2023
Figure 16. Global Orlistat Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Orlistat Players: Market Share by Revenue in 2023
Figure 18. Orlistat Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Orlistat Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Orlistat Sales Market Share by Country (2019-2030)
Figure 21. North America Orlistat Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Orlistat Sales Market Share by Country (2019-2030)
Figure 25. Europe Orlistat Revenue Market Share by Country (2019-2030)
Figure 26. Germany Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Orlistat Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Orlistat Revenue Market Share by Region (2019-2030)
Figure 33. China Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Orlistat Sales Market Share by Country (2019-2030)
Figure 44. Latin America Orlistat Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Orlistat Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Orlistat Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Orlistat Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Orlistat by Type (2019-2030)
Figure 54. Global Revenue Market Share of Orlistat by Type (2019-2030)
Figure 55. Global Orlistat Price (USD/Pcs) by Type (2019-2030)
Figure 56. Global Sales Market Share of Orlistat by Application (2019-2030)
Figure 57. Global Revenue Market Share of Orlistat by Application (2019-2030)
Figure 58. Global Orlistat Price (USD/Pcs) by Application (2019-2030)
Figure 59. Orlistat Value Chain
Figure 60. Orlistat Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
